Abstract
INTRODUCTION
A pyogenic liver abscess (PLA) is the most common type of visceral abscess and is a potentially lifethreatening disease with distinct incidence rates worldwide [1] [2] [3] . In western countries, the annual PLA incidence rate is around 1-2.3 per 100000 [2] [3] [4] with an overall mortality of around 10% [2, 4, 5] . In Taiwan, the annual incidence has increased steadily from 11.2 per 100000 in 1996 to 17.6 per 100000 in 2004 [1] . The direct ascending spread of bacteria from the biliary tract or a hematologic spread of bacteria from organs of the portal systems due to gastrointestinal lesions with mucosa defects or a compromised mucosa barrier [5, 6] , is the well-known pathogenesis. Therefore, the documented risk factors for PLA include diabetes mellitus (DM) [1, 7] , end-stage renal disease (ESRD) [8, 9] , biliary tract infection (BTI) [10] , liver cirrhosis [11, 12] , colorectal cancer [13] [14] [15] [16] [17] , hepatobiliary tract cancer [18, 19] , and endoscopic retrograde cholangiopancreatography (ERCP)-related biliary tract procedures [20] [21] [22] [23] . In addition, serial case reports have also demonstrated that acute appendicitis or diverticulitis may result in PLA through bacterial spreading from portal systems [24] [25] [26] [27] [28] [29] . Gastrointestinal (GI) endoscopies are common procedures for the diagnosis and treatment of GI diseases. Although the risk of adverse events associated with these procedures is low, complications still occasionally happen under extensive usage. Common complications of GI endoscopy include perforation, hemorrhage, and infection. According to the literature, the mean rate of bacteremia after ERCP ranges from 6.4% to 18% [21] . These bacteremia episodes may evolve into clinical complications, including cholangitis, cholecystitis, PLA, pancreatic pseudocyst infection and even sepsis, at a rate ranging from 0.04% to 8.6% [20] [21] [22] [23] . Hence, prophylaxis antibiotics are recommended for patients who receive ERCP with a bile duct obstruction and without adequate biliary drainage [20] . Transient bacteremia after a diagnostic upper GI (UGI) panendoscopy and colonoscopy has also been reported to occur at a mean rate of 4.4% [20, 30, 31] . Therefore, the development of PLA after a GI endoscopy through the hemorrhagic spread of bacteria is possible [20, 24, [31] [32] [33] .
Until now, no large-scale study has been conducted to investigate the relationship between GI endoscopy and the subsequent risk of PLA. The aim of this study was to determine whether patients who had undergone a recent GI endoscopy had an increased risk of PLA compared to those who had not undergone GI endoscopy, based on a nationwide population-based database in Taiwan.
MATERIALS AND METHODS

Data source
This study was based on claims data from the Taiwan National Health Insurance (NHI) program, which was initiated in 1995 to provide affordable healthcare for all residents in Taiwan 
Study population and design
The present study was designed as a nested casecontrol study. We used LHID 2005 to identify patients with first-diagnosed PLA (International Classification  of Disease, 9 th Revision, Clinical Modification [ICD-9-CM], code 572.0) from either outpatient or inpatient medical records from 1998 to 2011. The diagnosis date of PLA served as the index date. For each patient with PLA, five matched controls were selected from the remaining patients in the database using an incidence density sampling method [34] . The controls were randomly selected from people who had a matched birth year and sex, and who had not been diagnosed with PLA from 1997 to the PLA occurrence date (index date) of their matched cases ( Figure 1 ).
Criteria and definitions
To evaluate the association between a recent digestive endoscopy and PLA, we reviewed inpatient and outpatient medical records of cases and controls in the 90 d period before the index date ( Figure 1 ). Since the bureau of NHI regularly checked the claims dataset to ensure the validity of all procedure codes that patients received before reimbursement, we believe that the above endoscopy procedure records should be reliable. There was also a possibility that the patients who received endoscopic procedures were not recorded in the NHI database. For example, patients who received self-paid endoscopic procedures were not included. However, the NHI program covers near 100% of Taiwan's entire population. The ratio of these self-paid endoscopic procedures was extremely low and can almost be neglected. In addition to demographic variables, documented risk factors for PLA, including diabetes mellitus (ICD-9-CM code 250), BTI (ICD-9-CM codes 574.0-574.4, 575.0, 575.1, 575.10-575.12, and 576.1-576.3), liver cirrhosis (ICD-9-CM codes 571.2, 571.5, and 571.6), appendicitis (ICD-9-CM codes 540.0, 540.1, 541, and 542) and diverticulitis (ICD-9-CM codes 562.10-562.13), were also identified during the 15 mo (90 + 365 d) before the index date ( Figure 1 ). Moreover, patients with ESRD or GI malignancies that were registered in the Critical Illness Database of NHIRD before the index date (not limited to the 15-month duration before the index date), were also identified ( Figure 1 ). Malignancies of the GI tract included malignancies of colon (ICD-9-CM codes 153.0-153.9), rectosigmoid junction (154.0), rectum 9.3, SAS Institute Inc., Cary, NC, United States). In addition to the analysis of a recent 90 d GI endoscopy and PLA risk, we also conducted another sensitivity analysis of a recent 180 d and 1 year (365 d) GI endoscopy by the aforementioned methods to validate the association between GI endoscopy and PLA risk.
RESULTS
Demographics and comorbidities
During 1998 to 2011, 2135 PLA cases and 10675 matched controls were obtained from LHID 2005. The annual PLA incidence in Taiwan during this period was 15.25 cases per 100000. The mean age was 58.9 ± 16.5 year and 60% were males. PLA mostly happened in those aged 45-64 year (41.4%). The leading comorbidities of patients with PLA were BTI (11.7%), diabetes (9.7%), and liver cirrhosis (6.8%) ( Table 1) . Patients with PLA were more likely to have the following comorbidities than patients without PLA: diabetes (p < 0.001), ESRD (p < 0.001), BTI (p < 0.001), liver cirrhosis (p < 0.001), malignancies of the GI tract (p < 0.001), appendicitis (p < 0.001), and diverticulitis (p < 0.001) ( Table 1 ). 
Statistical analysis
Frequencies of demographic and clinical characteristics were described and compared between cases and controls using χ 2 test. To evaluate the net effect of a recent UGI panendoscopy or LGI endoscopy on PLA risk, a multivariate analysis adjustment for the well documented or possible risk factors for PLA was conducted. The frequency of OPD visits and the frequency of abdominal ultrasound examinations were also adjusted to prevent a usage dependency bias for patients who had other risk and confounding factors of PLA which would lead to a higher frequency of OPD visits and ultrasound examinations. A conditional logistic regression model was performed to estimate the adjusted odds ratio (OR) and its 95% confidence interval (CI). Significance was set at p < 0.05. All statistical analyses were performed using SAS (version People who had never been diagnosed as PLA at and prior to the incidence of the PLA cases to be matched 
Examinations and risk of pyogenic liver abscess
During the 90 d period before the index date, patients with PLA had a significantly higher rate of having undergone an UGI panendoscopy (p < 0.001), LGI endoscopy (p < 0.001), and ERCP-related procedures (p < 0.001) than patients without PLA. Fifty seven (33.1%) PLA cases occurred within the first 10 d after an endoscopic examination ( Figure 2) , with a median of 25.5 d (interquartile range, 7-53 d). Moreover, the frequency of OPD visits (p < 0.001) and frequency of abdominal ultrasound examinations (p < 0.001) during the 90 d period before the index date were also significantly higher in patients with PLA ( Table 2 ).
The net effect of a recent UGI panendoscopy and LGI endoscopy and PLA risk was evaluated by a multivariate analysis after adjusting for risk factors for PLA, recent ERCP-related procedures, and frequency of OPD visits and abdominal ultrasounds ( Table 3 ). The results showed that patients who had undergone a recent UGI panendoscopy had significantly higher odds of having PLA than patients who had not undergone an UGI panendoscopy (OR = 2.75, 95%CI: 2.05-3.69, p < 0.001). The number needed to harm (NNH) for UGI panendoscopy in PLA was 15 patients (95%CI: 12-17). However, there was no significant difference between patients with or without a LGI endoscopy (OR = 1.07, 95%CI: 0.62-1.86, p = 0.803). Because 4.23-7.64, p < 0.001), and ERCP-related procedures (OR = 27.04, 95%CI: 11.65-62.72, p < 0.001), which have been documented previously as PLA risk factors, were also significantly associated with PLA in this study. Additionally, patients with a history of appendicitis (OR = 3.16, 95%CI: 2.27-4.41, p < 0.001) or diverticulitis (OR = 1.64, 95%CI: 1.01-2.64, p = 0.044) also had significantly higher odds of having PLA than patients without appendicitis or diverticulitis, but the case numbers of these two illnesses were small ( Table 3) .
Comorbidities and risk of pyogenic liver abscess
Invasiveness of endoscopy and risk of pyogenic liver abscess
We further analyzed the association between the risk of PLA and the invasiveness of UGI or LGI tract endoscopy. The results showed no significant association with PLA risk on whether the invasive procedures were performed or not in both an UGI panendoscopy (OR = 0.91, 95%CI: 0.47-1.77) and LGI endoscopy (OR = 0.97, 95%CI: 0.32-2.96) ( Table 4) .
DISCUSSION
This large nested case-control study has shown a significant association between a recent UGI panendoscopy and increased risk of PLA (OR = 2.75, 95%CI: 2.05-3.69, NNH = 15). However, a LGI endoscopy and the invasive procedure itself of a GI endoscopy did not seem to increase the risk of PLA.
Bacterial translocation of GI microbial flora into the bloodstream may occur during an endoscopy due to mucosal injury. Although the risk of infection in remote tissues (i.e., infective endocarditis) caused by endoscopy-related transient bacteremia is extremely low, local infection may occur in which a typically sterile space or tissue is breached and contaminated by an endoscopic accessory [20, 21] . Once the local infection progresses, it may develop into portal venous bacteremia and lead to PLA. Previous studies have shown that bacteremia occurred mostly within 30 min after GI endoscopy [21] .
In the present study, we found that 33.1% of PLA occurred within 10 d after an UGI panendoscopy. In addition, UGI panendoscopy in the previous 90 d had higher OR for PLA than the previous 180 d and 1 year panendoscopy. As the PLA occurred after UGI panendoscopy and the OR subsided with time, a causal relationship between them is very likely. Though the mean duration that PLA occurred after an UGI panendoscopy was 32 d (median 25.5 d), the shortest duration of finding the PLA after panendoscopy was only 1 d. Therefore, the possibility of a PLA coincidentally exists when receiving panendoscopy could not be ignored, because some patients with early PLA may also present upper GI symptoms which lead them to receive an UGI panendoscopy. The reasonable incubation time of developing PLA after panendoscopy is an interesting and important issue and deserves further study. Our study also demonstrated that an UGI panendoscopy was significantly associated with a subsequent risk of PLA, but a LGI endoscopy was not. The distance between the liver and the examined organs may be the reason for this finding. For example, the colon is further away from the portal venous and lymphatic circulations to the liver than the esophagus, stomach, and duodenum, therefore a LGI endoscopy might have a lower probability of occurrence of PLA. Moreover, a complicated mesenteric lymphatic defense system in the LGI tract may also decrease the probability of portal venous bacteremia induced by a LGI endoscopy. In addition, high intraluminal air pressure due to air inflation during a duodenum examination in an UGI panendoscopy may also increase the additional risk of retrograde bacterial translocation from the biliary tract and increase the probability of PLA. All of the above factors may explain our findings that an UGI panendoscopy was significantly associated with a subsequent higher risk of PLA than a LGI endoscopy.
In theory, invasive procedures including biopsy, polypectomy, hemostasis, or foreign body removal will result in direct mucosal damage. Presumably, the risk of bacterial translocation into local tissue or circulation will increase due to the endogenous microbial flora gaining a portal of entry. Previous studies have shown that an interventional endoscopy may cause a higher incidence of bacteremia [21, 35] . Hence, prophylaxis antibiotics were suggested for some high risk procedures, especially in patients with liver cirrhosis and acute GI bleeding or valvular heart disease [35, 36] . However, in this study we found no significant difference in the risk of PLA between a GI endoscopy with and without invasive procedures. One explanation is that an UGI panendoscopy itself is invasive enough to result in an increased risk of PLA. Another possibility may be that some patients receiving invasive procedures were prescribed with prophylactic antibiotics or had concurrent antibiotics usage. Thus, it prevented the development of PLA, since the use of antibiotics has been recommended for invasive procedures with a high risk of bacteremia [20, 21, 37] . PLA secondary to inflammatory diseases of the GI tract, like acute appendicitis or diverticulitis, have been described in serial case reports through the mechanism of portal bacteremia [25] [26] [27] [28] [29] , but scarcely studies have verified their association. Recently, one study demonstrated appendectomy correlates with increased risk of PLA [38] . In our study, we identified patients with a diagnosis of acute appendicitis or diverticulitis during the 15 mo before having PLA. Although the ratio and sample size of a history of acute appendicitis or diverticulitis in patients with PLA were small [0.47% (n = 10) and 0.56% (n = 12), respectively, Table 1 ], both were significantly associated with an increased risk of PLA (OR = 3.16, 95%CI: 2.27-4.41 in acute appendicitis; and OR = 1.64, 95%CI: 1.01-2.64 in diverticulitis; Table 3 ). This finding should remind us that PLA may develop after having appendicitis or diverticulitis.
Because the dataset of this study has covered over a decade of cases, we also take the change of endoscopy procedure into consideration. The mostrelated points are the infection controls for the procedures, which has meant the carrying of lower infectious complications and it has highlighted the high level and up-to-date GI endoscopy disinfection procedures in Taiwan [39, 40] . The etiology for the development of PLA after GI endoscopy can be iatrogenic and the positive bacterial culture rate from these GI instruments could be high [40] . Hence, manual washing, automated endoscope washer reprocessing and adequate drying/storage after rinsing with regular surveillance culture were recently advised to diminish iatrogenic infectious complications [40] . The use of a representative, nationwide, populationbased sample to investigate the risk factors of PLA increases the validity of our results. This large sample size granted us the statistical power to detect differences between the study groups. Nevertheless, there are several limitations in the present study. First, similar to other studies that used administrative data, unmeasured confounders may exist in our study. Second, the use of prophylactic antibiotics for patients who underwent invasive endoscopy was not considered in the analysis, which might confine the interpretation of the antibiotics on reducing the risk of PLA. Third, because the study was based on an administrate claims dataset, the diagnosis of PLA was defined by ICD-9-CM rather than detail clinical information, coding error is possible. Further validation may be needed. However, the NHI regularly checked the claims dataset to ensure the validity before reimbursement, we believe the ratio of coding error is extremely low [41] . In addition, the NHIRD has been extensively used in research, the same definition of PLA has been published in peer-reviewed journals previously [7] [8] [9] 42] . Finally, a lack of microbiologic data limited the analysis of the association among causative pathogens, site of endoscopy, and PLA. Further study with a larger sample size that adjusts for the influence of concurrent antibiotic use may be needed to verify these findings.
In conclusion, a higher risk of PLA was found in patients who had recently undergone an UGI panendoscopy, especially within the first 10 d after panendoscopy. Clinical physician should not ignore the risk of development of PLA after patients receiving an UGI panendoscopy, especially in those with diabetes mellitus, ESRD, liver cirrhosis, BTI, and GI malignancies.
COMMENTS
Background
A pyogenic liver abscess (PLA) is a potential lethal disease with known pathogeneses, including biliary tract infection (BTI) and portal venous bacterial spreading. Gastrointestinal (GI) endoscopies are common procedures that sometimes have complications of mucosa trauma, local infection, and bacteremia. The relationship between GI endoscopy and subsequent PLA has not been documented.
Research frontiers
This study investigates the association between a recent GI endoscopy and the subsequent risk of PLA.
Innovations and breakthroughs
A higher risk of PLA was found in patients who had recently undergone an upper GI panendoscopy, especially within the first 10 d after panendoscopy. Furthermore, patients with diabetes mellitus, end-stage renal disease, liver cirrhosis, BTI, and GI malignancies also could have a much higher risk of PLA.
Applications
These findings remind clinical physician that PLA may occur in those high-risk patients when they undergo an upper GI panendoscopy.
